Investigating how amyloid proteins clump together and finding ways to stop it
Development of novel computational protocols to study amyloid oligomerization
This study is looking at how certain proteins clump together in the brain, which is connected to Alzheimer's disease, and it aims to find ways to stop this process using existing medications and natural substances, as well as exploring physical therapies that might help, so that patients can benefit from new treatments or ways to prevent the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10901936 on NIH RePORTER |
What this research studies
This research focuses on understanding the process by which amyloid proteins aggregate, which is linked to neurodegenerative diseases like Alzheimer's. Using advanced computational methods, the team will simulate the behavior of these proteins and identify potential inhibitors from existing drugs and natural compounds. Additionally, the research aims to explore physical therapies that could help eliminate harmful amyloid oligomers. Patients may benefit from insights that could lead to new treatments or preventive strategies against Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those in the early stages of cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those not exhibiting amyloid-related pathology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent or slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in targeting amyloid aggregation, suggesting that this approach could yield significant advancements in treatment.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Man, Viet Hoang — University of Pittsburgh at Pittsburgh
- Study coordinator: Man, Viet Hoang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.